Potassium phosphate
BLOOD AND BLOOD FORMING ORGANS
Also known as: potassium orthophosphate, tripotassium phosphate
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Potassium phosphate is a drug catalogued in DrugCentral.
- ATC code: B05XA06 (Electrolyte solutions).
- Molecular formula: K3O4P; molecular weight 212.26 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Off-label uses (2)
- Calcium renal calculus
- Hypophosphatemia
Contraindications (26)
- Acute nephropathy
- Anuria
- Azotemia
- Body fluid retention
- Chronic heart failure
- Cirrhosis of liver
- Congenital myotonia, autosomal dominant form
- Edema
- End stage renal disease
- Heart disease
- Hepatic failure
- Humoral hypercalcemia of malignancy
- Hypercalcemia
- Hypercalciuria
- Hyperkalemia
- Hypernatremia
- Hyperphosphatemia
- Hypocalcemia
- Hyporeninemic hypoaldosteronism
- Kidney disease
- Kidney stone
- Oliguria
- Poisoning by digitalis glycoside
- Sarcoidosis
- Severe dehydration
- Ventricular fibrillation
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
B05XA06 | BLOOD AND BLOOD FORMING ORGANS › BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS › I.V. SOLUTION ADDITIVES › Electrolyte solutions |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Cytokine release syndrome | 84.6 |
| Encephalopathy | 48.4 |
| Myocardial reperfusion injury | 44.5 |
| Toxic epidermal necrolysis | 38.5 |
| Nephrocalcinosis | 33.4 |
Chemical structure
| Molecular formula | K3O4P |
|---|---|
| Molecular weight | 212.26 g/mol |
| CAS number | 7778-53-2 |
| InChIKey | — |
| PubChem CID | 516951 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is the chemical formula of Potassium phosphate?
Potassium phosphate has the molecular formula K3O4P and a molecular weight of 212.26 g/mol.
Browse: all drugs starting with P · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 4527 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL4298074 — compound record and bioactivity
- PubChem CID 516951 — chemical identifiers
- DrugBank DB09413 — drug record
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.